Clinical trialNCT05535738Active, not recruitingPhase 2/PHASE3Interventional

Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

SponsorWei-Che KoEnrollment45Allergic Contact DermatitisSkin Inflammation

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to answer: how do inflammation and anti-inflammatory skin therapies work in the skin? Inflammation is a protective response from the body's immune system to injury, disease, or irritation. It is a process by which your body's white blood cells and the things they make protect you from infection from outside invaders such as bacteria and viruses.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Wei-Che Ko, MD
University of Massachusetts, Worcester
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Massachusetts Chan Medical School
Worcester, Massachusetts, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Adalimumab →Betamethasone →Canakinumab →Dupilumab →Fluticasone →Guselkumab →Sarilumab →Squaric acid dibutyl esterTriamcinolone →Ustekinumab →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 15 Nov 2022
Primary completion: 1 Jan 2027
Completion: 31 Dec 2027
Last update posted: 9 Jun 2026
Registered enrollment: 45
Registry id: NCT05535738

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.